Literature DB >> 24226529

Differential diagnosis of steroid-dependent nephrotic syndrome with psychosis: Practical and ethical issues.

C K Westergaard1, C J Nowinski, J J Sweet.   

Abstract

The present case illustrates practical and ethical issues that can be encountered by clinical psychologists providing consultation services in medical settings. The neuropsychological consultation service was asked to evaluate a 22-year-old male with psychosis, steroid-dependent nephrotic syndrome, and a family history of schizophrenia. MRI revealedmarked cortical atrophy. Clinical findings were consistent with (1) steroid inducedapparent atrophy, which has been shown to be reversible with withdrawal of steroids; (2) uremia secondary to steroid withdrawal; (3) cortical atrophy, found in some schizophrenics; or (4) an atypical, diffuse degenerative disorder. Clinical interview and psychological testing revealed significant thought disorder, prominent delusions, somatic hallucinations, and mood disturbance. Deterioration in social and academic functioning was also present. Except for impaired attention and concentration, neuropsychological evaluation showed no clear evidence of brain-based dysfunction. Further, neuropsychological results effectively ruled out a degenerative process and were not consistent with a steroid effects profile. A conclusive differential diagnosis of steroid induced psychosis versus severe psychopathology would require withdrawal from steroids and antipsychotics. In addition to the practical and ethical issues of withholding antipsychotics, steroid withdrawal would require either dialysis or renal transplant surgery. Decision making regarding dialysis dependency and the possibility of postsurgical psychosis secondary to true psychopathology were salient issues to both the patient and the treatment team.

Entities:  

Year:  1996        PMID: 24226529     DOI: 10.1007/BF01989286

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  7 in total

1.  Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome.

Authors:  E R Heinz; J Martinez; A Haenggeli
Journal:  J Comput Assist Tomogr       Date:  1977-10       Impact factor: 1.826

Review 2.  Anabolic-androgenic steroids and psychiatric-related effects: a review.

Authors:  L Uzych
Journal:  Can J Psychiatry       Date:  1992-02       Impact factor: 4.356

3.  Neuropsychological patterns in uremia.

Authors:  G T Souheaver; J J Ryan; A S DeWolfe
Journal:  J Clin Psychol       Date:  1982-07

4.  Steroids and apparent cerebral atrophy on computed tomography scans.

Authors:  J Bentson; M Reza; J Winter; G Wilson
Journal:  J Comput Assist Tomogr       Date:  1978-01       Impact factor: 1.826

5.  Cerebral atrophy following ACTH therapy.

Authors:  T Okuno; M Ito; Y Konishi; M Yoshioka; Y Nakano
Journal:  J Comput Assist Tomogr       Date:  1980-02       Impact factor: 1.826

Review 6.  Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids.

Authors:  O M Wolkowitz
Journal:  Psychoneuroendocrinology       Date:  1994       Impact factor: 4.905

Review 7.  Adverse psychiatric effects of systemic glucocorticoid therapy.

Authors:  J F Klein
Journal:  Am Fam Physician       Date:  1992-11       Impact factor: 3.292

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.